Clonal progression of prostate cancers from Gleason grade 3 to grade 4. (Q34498069)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23204237 AND SRC:MED&resulttype=core&format=json

19 February 2020

title

Clonal progression of prostate cancers from Gleason grade 3 to grade 4 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23204237 AND SRC:MED&resulttype=core&format=json

19 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23204237 AND SRC:MED&resulttype=core&format=json

19 February 2020

author name string

Huihui Ye

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23204237 AND SRC:MED&resulttype=core&format=json

19 February 2020

Glenn J Bubley

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23204237 AND SRC:MED&resulttype=core&format=json

19 February 2020

Steven P Balk

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23204237 AND SRC:MED&resulttype=core&format=json

19 February 2020

language of work or name

English

0 references

publication date

30 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23204237 AND SRC:MED&resulttype=core&format=json

19 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23204237 AND SRC:MED&resulttype=core&format=json

19 February 2020

volume

73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23204237 AND SRC:MED&resulttype=core&format=json

19 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23204237 AND SRC:MED&resulttype=core&format=json

19 February 2020

page(s)

1050-1055

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23204237 AND SRC:MED&resulttype=core&format=json

PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients

19 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587758

Predicting 15-year prostate cancer specific mortality after radical prostatectomy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587758

Molecular analysis of multifocal prostate cancer by comparative genomic hybridization

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587758

Change in prostate cancer grade over time in men followed expectantly for stage T1c disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587758

TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: clinical and biologic implications

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587758

Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587758

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587758

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587758

20-year outcomes following conservative management of clinically localized prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587758

Evidence of Independent Origin of Multiple Tumors From Patients With Prostate Cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587758

Precise microdissection of human prostate cancers reveals genotypic heterogeneity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587758

Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587758

Active Surveillance Program for Prostate Cancer: An Update of the Johns Hopkins Experience

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587758

Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587758

Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587758

Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587758

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587758

Dedifferentiation of prostate cancer grade with time in men followed expectantly for stage T1c disease

27 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23204237

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Allelic imbalance in the clonal evolution of prostate carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23204237

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

ERG Transcription Factor as an Immunohistochemical Marker for Vascular Endothelial Tumors and Prostatic Carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23204237

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/0008-5472.CAN-12-2799

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23204237 AND SRC:MED&resulttype=core&format=json

19 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23204237 AND SRC:MED&resulttype=core&format=json

19 February 2020

PubMed publication ID

23204237

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23204237 AND SRC:MED&resulttype=core&format=json